Piper Sandler analyst Jason Bednar reiterated a Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report) today and set a price target of $7.00. The company’s shares closed yesterday at $3.03.
Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Cooper Co, and Merit Medical Systems. According to TipRanks, Bednar has an average return of -3.9% and a 40.99% success rate on recommended stocks.
Currently, the analyst consensus on Alpha Tau Medical Ltd is a Moderate Buy with an average price target of $7.50.
See the top stocks recommended by analysts >>
The company has a one-year high of $4.80 and a one-year low of $2.70. Currently, Alpha Tau Medical Ltd has an average volume of 37.71K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alpha Tau Medical Ltd (DRTS) Company Description:
Alpha Tau is an Israel-based medical device company focusing on the research, development, and potential commercialization of the Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid tumors.
Read More on DRTS:
